​

60 Degrees Pharmaceuticals (SXTP) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

60 Degrees Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$607.57K

Latest Revenue (Q)

$162.09K

60 Degrees Pharmaceuticals Revenue by Period

60 Degrees Pharmaceuticals Revenue by Year

DateRevenueChange
2024-12-31$607.57K139.61%
2023-12-31$253.57K13.60%
2022-12-31$223.21K-80.76%
2021-12-31$1.16M-46.81%
2020-12-31$2.18M-

60 Degrees Pharmaceuticals generated $607.57K in revenue during NA 2024, up 139.61% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

60 Degrees Pharmaceuticals Revenue by Quarter

DateRevenueChange
2026-03-31$162.09K-46.57%
2025-12-31$303.38K-30.67%
2025-09-30$437.60K333.56%
2025-06-30$100.93K-38.29%
2025-03-31$163.55K-37.44%
2024-12-31$261.44K93.24%
2024-09-30$135.29K8.26%
2024-06-30$124.97K18.26%
2024-03-31$105.67K147.44%
2023-12-31$42.71K-16.57%
2023-09-30$51.19K-14.02%
2023-06-30$59.53K246.68%
2023-03-31$17.17K-122.70%
2022-12-31$-75.65K-144.98%
2022-09-30$168.19K272.31%
2022-06-30$45.17K-3.94%
2022-03-31$47.02K-83.60%
2021-12-31$286.64K-

60 Degrees Pharmaceuticals generated $162.09K in revenue during Q1 2026, up -46.57% compared to the previous quarter, and up 62.00% compared to the same period a year ago.

60 Degrees Pharmaceuticals Revenue Breakdown

60 Degrees Pharmaceuticals Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24
Service$10.79K$10.79K$10.79K
Product$135.29K$124.97K-

60 Degrees Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (92.61%), and Service (7.39%).

60 Degrees Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
JAGXJaguar Health$11.51M$1.20M
SXTP60 Degrees Pharmaceuticals$607.57K$162.09K
BDRXBiodexa Pharmaceuticals$381.00K$41.50K
SILOSilo Pharma$72.10K$18.03K
KZIAKazia Therapeutics$555.00$5.00
CNSPCNS Pharmaceuticals--
CMNDClearmind Medicine--
SNGXSoligenix--
GRIGRI Bio--

SXTP Revenue FAQ

What is 60 Degrees Pharmaceuticals’s yearly revenue?

60 Degrees Pharmaceuticals's yearly revenue for 2024 was $607.57K, representing an increase of 139.61% compared to 2023. The company's yearly revenue for 2023 was $253.57K, representing an increase of 13.60% compared to 2022. SXTP's yearly revenue for 2022 was $223.21K, representing a decrease of -80.76% compared to 2021.

What is 60 Degrees Pharmaceuticals’s quarterly revenue?

60 Degrees Pharmaceuticals's quarterly revenue for Q1 2026 was $162.09K, a -46.57% decrease from the previous quarter (Q4 2025), and a -0.89% decrease year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $303.38K, a -30.67% decrease from the previous quarter (Q3 2025), and a 16.04% increase year-over-year (Q4 2024). SXTP's quarterly revenue for Q3 2025 was $437.6K, a 333.56% increase from the previous quarter (Q2 2025), and a 223.45% increase year-over-year (Q3 2024).

What is 60 Degrees Pharmaceuticals’s revenue growth rate?

60 Degrees Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 172.20%, and for the last 5 years (2020-2024) was -72.15%.